Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals

Carina Sihlbom, Pia Davidsson, Magnus Sjögren, Lars Olof Wahlund, Carol L. Nilsson

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Glycoproteins in cerebrospinal fluid (CSF) are altered in Alzheimer's Disease (AD) patients compared to control individuals. We have utilized albumin depletion prior to 2D gel electrophoresis to enhance glycoprotein concentration for image analysis as well as structural glycoprotein determination without glycan release using mass spectrometry (MS). The benefits of a direct glycoprotein analysis approach include minimal sample manipulation and retention of structural details. A quantitative comparison of gel-separated glycoprotein isoforms from twelve AD patients and twelve control subjects was performed with glycoprotein-specific and total protein stains. We have also compared glycoforms in pooled CSF obtained from AD patients and control subjects with mass spectrometry. One isoform of α1-antitrypsin showed decreased glycosylation in AD patients while another glycosylated isoform of an unassigned protein was up-regulated. Protein expression levels of α1- antitrypsin were decreased, while the protein levels of apolipoprotein E and clusterin were increased in AD. No specific glycoform could be specifically assigned to AD.

Original languageEnglish (US)
Pages (from-to)1332-1340
Number of pages9
JournalNeurochemical Research
Volume33
Issue number7
DOIs
StatePublished - Jul 2008
Externally publishedYes

Fingerprint

Cerebrospinal fluid
Cerebrospinal Fluid
Glycoproteins
Alzheimer Disease
Protein Isoforms
Mass spectrometry
Mass Spectrometry
Gels
Clusterin
Glycosylation
Proteins
Electrophoresis, Gel, Two-Dimensional
Apolipoproteins E
Electrophoresis
Image analysis
Polysaccharides
Albumins
Coloring Agents

Keywords

  • α-1-β-glycoprotein
  • α- antitrypsin
  • Alzheimer's Disease
  • Apolipoprotein E
  • Cerebrospinal fluid
  • Clusterin
  • CSF
  • Glycoform
  • Glycoprotein
  • Glycoproteomics
  • Glycosylation
  • Haptoglobin
  • Isoform
  • N-linked
  • Proteomics

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry

Cite this

Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals. / Sihlbom, Carina; Davidsson, Pia; Sjögren, Magnus; Wahlund, Lars Olof; Nilsson, Carol L.

In: Neurochemical Research, Vol. 33, No. 7, 07.2008, p. 1332-1340.

Research output: Contribution to journalArticle

Sihlbom, Carina ; Davidsson, Pia ; Sjögren, Magnus ; Wahlund, Lars Olof ; Nilsson, Carol L. / Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals. In: Neurochemical Research. 2008 ; Vol. 33, No. 7. pp. 1332-1340.
@article{0f6fe26a960e40c39154bf7e35400f5d,
title = "Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals",
abstract = "Glycoproteins in cerebrospinal fluid (CSF) are altered in Alzheimer's Disease (AD) patients compared to control individuals. We have utilized albumin depletion prior to 2D gel electrophoresis to enhance glycoprotein concentration for image analysis as well as structural glycoprotein determination without glycan release using mass spectrometry (MS). The benefits of a direct glycoprotein analysis approach include minimal sample manipulation and retention of structural details. A quantitative comparison of gel-separated glycoprotein isoforms from twelve AD patients and twelve control subjects was performed with glycoprotein-specific and total protein stains. We have also compared glycoforms in pooled CSF obtained from AD patients and control subjects with mass spectrometry. One isoform of α1-antitrypsin showed decreased glycosylation in AD patients while another glycosylated isoform of an unassigned protein was up-regulated. Protein expression levels of α1- antitrypsin were decreased, while the protein levels of apolipoprotein E and clusterin were increased in AD. No specific glycoform could be specifically assigned to AD.",
keywords = "α-1-β-glycoprotein, α- antitrypsin, Alzheimer's Disease, Apolipoprotein E, Cerebrospinal fluid, Clusterin, CSF, Glycoform, Glycoprotein, Glycoproteomics, Glycosylation, Haptoglobin, Isoform, N-linked, Proteomics",
author = "Carina Sihlbom and Pia Davidsson and Magnus Sj{\"o}gren and Wahlund, {Lars Olof} and Nilsson, {Carol L.}",
year = "2008",
month = "7",
doi = "10.1007/s11064-008-9588-x",
language = "English (US)",
volume = "33",
pages = "1332--1340",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals

AU - Sihlbom, Carina

AU - Davidsson, Pia

AU - Sjögren, Magnus

AU - Wahlund, Lars Olof

AU - Nilsson, Carol L.

PY - 2008/7

Y1 - 2008/7

N2 - Glycoproteins in cerebrospinal fluid (CSF) are altered in Alzheimer's Disease (AD) patients compared to control individuals. We have utilized albumin depletion prior to 2D gel electrophoresis to enhance glycoprotein concentration for image analysis as well as structural glycoprotein determination without glycan release using mass spectrometry (MS). The benefits of a direct glycoprotein analysis approach include minimal sample manipulation and retention of structural details. A quantitative comparison of gel-separated glycoprotein isoforms from twelve AD patients and twelve control subjects was performed with glycoprotein-specific and total protein stains. We have also compared glycoforms in pooled CSF obtained from AD patients and control subjects with mass spectrometry. One isoform of α1-antitrypsin showed decreased glycosylation in AD patients while another glycosylated isoform of an unassigned protein was up-regulated. Protein expression levels of α1- antitrypsin were decreased, while the protein levels of apolipoprotein E and clusterin were increased in AD. No specific glycoform could be specifically assigned to AD.

AB - Glycoproteins in cerebrospinal fluid (CSF) are altered in Alzheimer's Disease (AD) patients compared to control individuals. We have utilized albumin depletion prior to 2D gel electrophoresis to enhance glycoprotein concentration for image analysis as well as structural glycoprotein determination without glycan release using mass spectrometry (MS). The benefits of a direct glycoprotein analysis approach include minimal sample manipulation and retention of structural details. A quantitative comparison of gel-separated glycoprotein isoforms from twelve AD patients and twelve control subjects was performed with glycoprotein-specific and total protein stains. We have also compared glycoforms in pooled CSF obtained from AD patients and control subjects with mass spectrometry. One isoform of α1-antitrypsin showed decreased glycosylation in AD patients while another glycosylated isoform of an unassigned protein was up-regulated. Protein expression levels of α1- antitrypsin were decreased, while the protein levels of apolipoprotein E and clusterin were increased in AD. No specific glycoform could be specifically assigned to AD.

KW - α-1-β-glycoprotein

KW - α- antitrypsin

KW - Alzheimer's Disease

KW - Apolipoprotein E

KW - Cerebrospinal fluid

KW - Clusterin

KW - CSF

KW - Glycoform

KW - Glycoprotein

KW - Glycoproteomics

KW - Glycosylation

KW - Haptoglobin

KW - Isoform

KW - N-linked

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=44549087658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44549087658&partnerID=8YFLogxK

U2 - 10.1007/s11064-008-9588-x

DO - 10.1007/s11064-008-9588-x

M3 - Article

VL - 33

SP - 1332

EP - 1340

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 7

ER -